STOCK TITAN
  1. Home
  2. Sec-filings
  3. TDOC
  4. [Form 4] Teladoc Health, Inc. Insider Trading Activity

Teladoc (TDOC) CAO sells shares after RSU vesting for tax withholding

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Teladoc Health, Inc. Chief Accounting Officer Joseph Ronald Catapano reported the vesting of restricted stock units and a related share sale. On July 1, 2026, 2,083 restricted stock units converted into the same number of common shares at a conversion price of $0.00 per share. According to the footnotes, these units convert to Teladoc common stock on a one-for-one basis and relate to a 25,000-unit grant awarded on October 1, 2024.

On July 2, 2026, 653 common shares were sold at $9.10 per share. A footnote explains that these shares were sold to cover the tax withholding obligation arising from the RSU vesting, indicating a compensation-related, non-discretionary sale rather than an ordinary portfolio transaction. Following these transactions, Catapano directly holds 12,267 Teladoc common shares, and 10,418 restricted stock units remain outstanding.

Positive

  • None.

Negative

  • None.
Insider Catapano Joseph Ronald
Role Chief Accounting Officer
Sold 653 shs ($6K)
Type Security Shares Price Value
Sale Common Stock 653 $9.10 $6K
Exercise Restricted Stock Units 2,083 $0.00 --
Exercise Common Stock 2,083 $0.00 --
Holdings After Transaction: Common Stock — 12,267 shares (Direct, null); Restricted Stock Units — 10,418 shares (Direct, null)
Footnotes (1)
  1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Shares sold 653 shares Sold at $9.10 per share on July 2, 2026
Sale price $9.10/share Price for 653 Teladoc common shares sold
RSUs vested 2,083 units Restricted stock units converted to common stock on July 1, 2026
Shares held after 12,267 shares Direct Teladoc common stock ownership following transactions
RSUs remaining 10,418 units Restricted stock units outstanding after the July 1, 2026 vesting
Original RSU grant 25,000 units Grant on October 1, 2024 with staged vesting schedule
Restricted stock units financial
"Restricted stock units convert to shares of TDOC common stock on a one-for-one basis"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
tax withholding obligation financial
"Shares sold to cover the tax withholding obligation in respect of vesting"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Catapano Joseph Ronald
(Last)(First)(Middle)
C/O TELADOC HEALTH, INC.,
155 E 44TH ST, SUITE 1700
(Street)
NEW YORK NEW YORK 10017
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Teladoc Health, Inc. [ TDOC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Accounting Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/01/2026M2,083A(1)12,920D
Common Stock07/02/2026S653(2)D$9.112,267D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)07/01/2026M2,083 (3) (3)Common Stock2,083$010,418D
Explanation of Responses:
1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis
2. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
3. On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Remarks:
/s/ Adam C. Vandervoort, Attorney-in-Fact07/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Teladoc (TDOC) report for Joseph Ronald Catapano?

Teladoc’s Chief Accounting Officer reported RSU vesting and a related tax sale. 2,083 restricted stock units converted into common shares, and 653 shares were sold, primarily to satisfy tax withholding obligations tied to the vesting event.

How many Teladoc (TDOC) shares did the CAO sell and at what price?

Joseph Ronald Catapano sold 653 Teladoc common shares at $9.10 per share. A filing footnote states the sale’s purpose was covering tax withholding from restricted stock unit vesting, rather than a discretionary portfolio sale.

How many Teladoc (TDOC) restricted stock units vested in this Form 4 filing?

The filing shows 2,083 restricted stock units converted into an equal number of Teladoc common shares. These units are part of a 25,000-unit RSU grant from October 1, 2024, vesting over time under a defined anniversary and quarterly schedule.

What are Joseph Ronald Catapano’s Teladoc (TDOC) holdings after these transactions?

After the reported transactions, Catapano directly holds 12,267 Teladoc common shares. In addition, 10,418 restricted stock units remain outstanding, which can convert into common shares in future vesting events under the original award terms.

Was the Teladoc (TDOC) insider share sale part of regular compensation tax withholding?

Yes. A footnote explains the 653 Teladoc shares were sold to cover tax withholding obligations on vested restricted stock units. This characterizes the sale as compensation-related and mechanistic, not a discretionary decision to reduce overall equity exposure.